TPI Polene Power Pcl, Thailand’s largest producer of waste-derived power, plans to raise up to 17.5 billion baht ($500.4 million) in an initial public offering, in what could be the country’s largest IPO in more than a decade.

The company plans to sell up to 2.5 billion shares, or a 30 percent stake, at a rate of 6 baht-7 baht ($0.17-$0.20) per share, parent firm TPI Polene Pcl said in a statement to the stock exchange on Friday.

Of the total, up to 125 million shares will be offered to TPI Polene’s existing shareholders on March 22-March 24, and the rest will be sold to the public on March 24-March 29, it said.

The power firm has said the sale proceeds will be used mainly to finance capacity expansion.

TPI Polene Power runs four plants with a total installed capacity of 150 MW. Two of the plants, with a combined capacity of 80 MW, use fuel derived from refuse, while the other two generate power from waste heat.

Maybank Kim Eng Securities Pcl, Tisco Bank and CIMB Thai Bank are financial advisers on the IPO.

 

The post Thailand’s TPI Polene Power to raise up to $500m in IPO appeared first on DealStreetAsia.

About the author

DEALSTREETASIA Pte. Ltd. is a news and intelligence platform providing reports on investments, mergers, acquisitions, private equity, venture capital, investment banking and the business of startups across the Asian region.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You May Also Like

Asia’s heat wave worsens as Russia’s war in Ukraine lingers

As a heat wave scorches Asia, many countries are ramping up their use of coal to meet energy demands, reversing years of progress in transitioning to cleaner fuels. The Russia-Ukraine conflict has also disrupted the LNG market, causing global shortages and price hikes.

Why is the air quality so bad in Thailand?

The World Health Organization (WHO) recommends that the annual average PM2.5 level should not exceed 10 micrograms per cubic meter (μg/m3), but Thailand’s average was 64 μg/m3 in 2022, more than six times higher than the WHO guideline.